ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Psyence Group Inc (PK)

Psyence Group Inc (PK) (PSYGF)

0.0177
-0.00245
(-12.16%)
Closed May 01 4:00PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.0177
Bid
0.0022
Ask
0.0382
Volume
1,000
0.0177 Day's Range 0.0177
0.0127 52 Week Range 0.22
Market Cap
Previous Close
0.02015
Open
0.0177
Last Trade
1000
@
0.0177
Last Trade Time
Financial Volume
$ 18
VWAP
0.0177
Average Volume (3m)
66,891
Shares Outstanding
137,438,182
Dividend Yield
-
PE Ratio
-0.45
Earnings Per Share (EPS)
-0.04
Revenue
-
Net Profit
-6.08M

About Psyence Group Inc (PK)

Sector
Medicinal Chems,botanicl Pds
Industry
Real Estate Investment Trust
Website
Headquarters
Toronto, Ontario, Can
Founded
1994
Psyence Group Inc (PK) is listed in the Medicinal Chems,botanicl Pds sector of the OTCMarkets with ticker PSYGF. The last closing price for Psyence (PK) was $0.02. Over the last year, Psyence (PK) shares have traded in a share price range of $ 0.0127 to $ 0.22.

Psyence (PK) currently has 137,438,182 shares outstanding. The market capitalization of Psyence (PK) is $2.75 million. Psyence (PK) has a price to earnings ratio (PE ratio) of -0.45.

PSYGF Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.00245-12.1588089330.020150.020150.01778840.02015CS
40.003524.64788732390.01420.02240.01271923200.02131654CS
12-0.0103-36.78571428570.0280.04730.0127668910.02855954CS
26-0.1013-85.12605042020.1190.1190.0127568680.04008238CS
52-0.0759-81.08974358970.09360.220.0127356290.04241956CS
156-0.1861-91.31501472030.20380.89210.01193730.04715584CS
260-0.1861-91.31501472030.20380.89210.01193730.04715584CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CGCCanopy Growth Corporation
$ 14.89
(78.97%)
83.58M
AKLIAkili Inc
$ 0.39
(66.03%)
86.48M
GVVisionary Holdings Inc
$ 0.256
(60.00%)
2.18M
IMCCIM Cannabis Corporation
$ 0.88
(57.14%)
13.14M
GMMGlobal Mofy Metaverse Ltd
$ 1.46
(56.94%)
80.37M
CETXCemtrex Inc
$ 1.1499
(-35.40%)
575.64k
LICNLichen China Limited
$ 1.32
(-34.98%)
1.28M
BCLIBrainstorm Cell Therapeutics Inc
$ 0.3731
(-30.86%)
1.74M
NRXPNRX Pharmaceuticals Inc
$ 2.60
(-26.76%)
937.63k
HWHHWH International Inc
$ 1.92
(-25.58%)
3.96M
TLRYTilray Brands Inc
$ 2.475
(39.83%)
154.33M
SQQQProShares UltraPro Short QQQ
$ 11.95
(5.66%)
129.32M
TSLATesla Inc
$ 183.28
(-5.55%)
127.04M
JAGXJaguar Health Inc
$ 0.2146
(3.17%)
100.27M
EGOXNext e GO NV
$ 0.0307
(11.23%)
95.14M

PSYGF Discussion

View Posts
TooFrank TooFrank 1 year ago
Colorado just legalized ‘magic mushrooms,’ an idea that’s growing nationwide

The initiative allows for the use of psilocybin at state-regulated centers under the supervision of licensed facilitators.
It also legalizes personal private use, growing and sharing of psilocybin and psilocin, as well as three additional psychedelic compounds — DMT, ibogaine and mescaline — by adults over the age of 21. Retail sales are not permitted,…

https://www.cnbc.com/amp/2022/11/12/colorado-just-legalized-magic-mushrooms-an-idea-thats-growing-nationwide.html
👍️0
TooFrank TooFrank 2 years ago
Hannam & Partners Financial Promotion of PSYGF

Psyence Group (PSYGF)
First mover into palliative care market supported
by natural psilocybin production
https://psyence.com/wp-content/uploads/2022/09/Psyence_Initiation_FINAL.02.pdf

Hannam & Partners Disclamer
https://www.hannam.partners/disclaimer/
Any Research Product is likely to be considered a financial promotion for the purposes of the FCA Rules.

Any Research Product provided by Hannam & Partners (“H&P”) will constitute “non-independent research” for the purposes of the rules from time to time of the Financial Conduct Authority (“FCA Rules”). As such it will constitute a marketing communication, has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.
👍️0
TooFrank TooFrank 2 years ago
Psyence operates one of the first and only federally licensed commercial psilocybin production facilities in the world. Is licensed to cultivate and export psilocybin mushrooms for the legal, global medical market and commercial medical research market.

Preparing to send mushrooms to Canada and Spain for analysis and extraction.

The laboratory has also been expanded to having the capability and equipment to undertake in-process testing on site, crude extraction, as well as to generate Certificates of Analysis (COAs) and undertake testing of the end product.
👍️0
TooFrank TooFrank 2 years ago
Boom in psychedelic therapies

https://www.telegraph.co.uk/news/2022/08/20/magic-mushrooms-set-become-uks-ultimate-weapon-against-depression/

👍️0

Your Recent History

Delayed Upgrade Clock